Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease
Authors:
- R. R. LonserRLR. R. Lonser
- R. SchiffmanRSR. Schiffman
- R. A. RobisonRRR. A. Robison
- J. A. ButmanJBJ. A. Butman
- Z. QuezadoZQZ. Quezado
- M. L. WalkerMWM. L. Walker
- P. F. MorrisonPMP. F. Morrison
- S. WalbridgeSWS. Walbridge
- G. J. MurrayGMG. J. Murray
- D. M. ParkDPD. M. Park
- R. O. BradyRBR. O. Brady
- E. H. OldfieldEOE. H. Oldfield
- 23 January 2007
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 68 (4) , 254-261
Abstract
Objective: To determine if convection-enhanced delivery (CED) of glucocerebrosidase could be used to treat targeted sites of disease progression in the brain and brainstem of a patient with neuronopathic Gaucher disease while monitoring enzyme distribution using MRI. Methods: A CED paradigm in rodents (n = 8) and primates (n = 5) that employs co-infusion of a surrogate MRI tracer (gadolinium diethylenetriamine penta-acetic acid [Gd-DTPA]) with glucocerebrosidase to permit real-time monitoring of distribution was developed. The safety and feasibility of this delivery and monitoring paradigm were evaluated in a patient with type 2 Gaucher disease. Results: Animal studies revealed that real-time, T1-weighted, MRI of Gd-DTPA accurately tracked enzyme distribution during CED. Targeted perfusion of clinically affected anatomic sites in a patient with neuronopathic Gaucher disease (frontal lobe and brainstem) with glucocerebrosidase was successfully performed. Real-time MRI revealed progressive and complete filling of the targeted region with enzyme and Gd-DTPA infusate. The patient tolerated the infusions without evidence of toxicity. Conclusions: Convection-enhanced delivery can be used to safely perfuse large regions of the brain and brainstem with therapeutic levels of glucocerebrosidase. Co-infused imaging surrogate tracers can be used to monitor and control the distribution of therapeutic agents in vivo. Patients with neuronopathic Gaucher disease and other intrinsic CNS disorders may benefit from a similar treatment paradigm.Keywords
This publication has 25 references indexed in Scilit:
- Local distribution and toxicity of prolonged hippocampal infusion of muscimolJournal of Neurosurgery, 2005
- Real-time in vivo imaging of the convective distribution of a low-molecular-weight tracerJournal of Neurosurgery, 2005
- Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusionJournal of Neurosurgery, 2002
- Convection-enhanced selective excitotoxic ablation of the neurons of the globus pallidus internus for treatment of parkinsonism in nonhuman primatesJournal of Neurosurgery, 1999
- Reversal of experimental parkinsonism by using selective chemical ablation of the medial globus pallidusJournal of Neurosurgery, 1999
- Direct convective delivery of macromolecules to peripheral nervesJournal of Neurosurgery, 1998
- Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with singlephoton emission computerized tomography imagingJournal of Neurosurgery, 1997
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- New Methods of Drug DeliveryScience, 1990
- Infantile Gaucher's Disease: Neuropathology, Acid Hydrolase Activities and Negative Staining Observations1Neuropediatrics, 1977